Companies: 10,795·Total market cap: $144.5T
Biofrontera Inc.

Biofrontera Inc.

BFRINASDAQHealthcare● Active
$0.93
$-0.01(-0.53%)
Market Cap$11907110
P/E Ratio—
52W High$1.19
52W Low$0.555
Overview
Stock ranking:Drug Manufacturers - Specialty & Generic·Healthcare·View All Market Cap Rankings →

Biofrontera Inc. (BFRI) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · BFRI · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-1.12bfri eps ttm · bfri earnings per shareEarnings history
PE Ratio (TTM)—bfri pe ratio ttm · bfri price to earningsPE Ratio deep dive
Revenue (TTM)$43.2Mbfri revenue ttm · bfri annual revenueFull revenue history
Dividend YieldNo Dividenddoes bfri pay dividends · bfri dividend yieldDividend history
Shares Outstanding10.2Mbfri shares outstanding · bfri floatShares outstanding history
Next EarningsAug 12, 2026Est.bfri earnings date · bfri next earningsEarnings history

Explore Biofrontera Inc. Data

bfri stock data · financials
Market Cap$11.9Mbfri market cap · bfri valuation
Analyst Forecast$— · Buy
DividendsNo Dividenddoes biofrontera inc. pay dividends · bfri dividend yield
Revenue$41.7M+11.80%biofrontera inc. annual revenue · bfri revenue
EarningsEPS $-1.04+67.70%bfri earnings · bfri eps
PE Ratio—bfri pe ratio · bfri price to earnings

Financial Snapshot

Full Financials
FY 2025Revenue$41.7M▲ +11.80% YoY
202320242025
biofrontera inc. revenue · bfri revenue 2025
FY 2025Net Income-$10.5M▲ +40.67% YoY
202320242025
biofrontera inc. net income · bfri profit 2025
FY 2025EPS$-1.04▲ +67.70% YoY
202320242025
bfri eps · biofrontera inc. earnings per share 2025
TTM:Revenue: $43.2MNet Income: -$11.1MEPS: $-1.12View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy1 analystsis bfri a buy · bfri analyst rating
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
12-Month Price Target
$—Low
$0.93Current
$—Avg Target
$—High
bfri price target · bfri 12 month forecast

Total: 1 · Buy rate: 100.0%

Stock Performance

Full History
1D-0.53%
1W-10.58%
1M-19.13%
3M+8.27%
YTD+63.16%
1Y+55.00%
5Y-98.95%

About Biofrontera Inc.

CEOHermann Luebbert
IPO DateOct 29, 2021
Employees92
CountryUS
Websitebiofrontera.us.com

Biofrontera Inc. is a biopharmaceutical enterprise dedicated to the marketing and distribution of pharmaceutical products within the United States, specifically targeting various dermatological condit…

Drug Manufacturers - Specialty & GenericHealthcareNASDAQUS

what is biofrontera inc. · bfri stock overview · biofrontera inc. company profile · who is biofrontera inc. ceo · bfri NASDAQ · biofrontera inc. headquarters · biofrontera inc. business segments

About Stock Overview & Key Data

Biofrontera Inc. (BFRI) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on NASDAQ since Oct 29, 2021. As of the latest trading session, BFRI stock price is $0.93, with a market capitalization of $11.9M. The stock has returned +55.00% over the past 12 months and +63.16% year-to-date.

According to 1 Wall Street analysts, the consensus rating for Biofrontera Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Biofrontera Inc. reported revenue of $41.7M and net income of -$10.5M. For detailed data — including Biofrontera Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Biofrontera Inc. (BFRI) stock price is $0.93. The stock is traded on NASDAQ under the ticker symbol BFRI. The 52-week range is $0.56 – $1.19.

BFRI stock priceBFRI quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice